Effects of pneumococcal conjugate vaccines on reducing the risk of respiratory disease associated with coronavirus infection
Description
Pneumococcal conjugate vaccines (PCVs) provide protection against vaccine-type pneumococcal disease in both children and adults. Growing evidence suggests that PCVs also reduce pneumonia and lower respiratory tract infections (LRTIs) more broadly
